Vivo Capital, LLC Rocket Pharmaceuticals, Inc. Transaction History

Vivo Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $13.5 Million - $20.5 Million	-310,584 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$23.3 - $59.57 $12.8 Million - $32.8 Million	-550,064 Reduced 63.91%	310,584 $17 Million
Q1 2020 May 15, 2020	BUY	$9.71 - $25.11 $8.36 Million - $21.6 Million	860,648 New	860,648 $12 Million
Q3 2019 Nov 13, 2019	SELL	$10.85 - $14.78 $8.54 Million - $11.6 Million	-786,712 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$15.0 - $19.81 $11.8 Million - $15.6 Million	786,712 New	786,712 $11.8 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.